Table 1.

Characteristics of kidney transplant recipients with COVID-19

CharacteristicsAll Patients, n=15
Baseline characteristics
 Age, yr51 (IQR, 28–72; range, 21–78)
 Female, n (%)5 (33)
 Time since transplant, mo49 (IQR, 38–118; range, 0–232)
 Deceased donor, n (%)12 (80)
 Multiorgan recipient, n (%)2 (13)
Maintenance immunosuppression, n (%)
 Tacrolimus14 (93)
 Mycophenolate mofetil or mycophenolic acid12 (80)
 Belatacept2 (13)
 Leflunomide1 (7)
 Azathioprine1 (7)
 Prednisone10 (67)
Clinical presentation, n (%)
 Fever13 (87)
 Cough9 (60)
 Fatigue/malaise4 (27)
 Dyspnea (exertional or rest)4 (27)
 Diarrhea3 (20)
 Myalgia2 (13)
 Hemoptysis1 (7)
 Emesis1 (7)
Laboratory tests on diagnosisa
 White blood cell count, ×1000/μl (n=13)4.8 (range, 2.1–12.7)
 Absolute lymphocyte count, /μl (n=11)800 (range, 110–1410)
 Ferritin, ng/ml (n=12)471 (range, 93–1963)
 Lactate dehydrogenase, U/L (n=12)275 (range, 113–450)
 Procalcitonin, ng/ml (n=13)0.46 (range, 0.08–18.7)
 Erythrocyte sedimentation rate, mm/h (n=12)40.5 (range, 0–75)
 C-reactive protein, mg/L (n=13)104 (range, 0.3–232)
 IL-6, pg/ml (n=12)24 (range, <5–120)
Initial chest x-ray, n (%)
 Multifocal/bilateral patchy opacities7 (47)
 No acute findings5 (33)
 Left lower lobe opacities1 (7)
 Right lower lobe opacity1 (7)
 Report not available1 (7)
  • Data are displayed as n (%), median (IQR), or median (range). COVID-19, coronavirus disease 2019; IQR, interquartile range.

  • a n<15 because of some patients being diagnosed at outside hospitals or as outpatients, or inconsistent laboratory test ordering upon admission.